Active ingredientMetopimazineCat. No. P-M109-001CAS 14008-44-7Family · Pharmaceutical analytical standards
Metopimazine
A phenothiazine antiemetic that blocks dopamine D2 receptors, presented as a new anti-vomiting drug in 1967 and used for nausea and vomiting, including chemotherapy-induced. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Like domperidone it crosses the blood-brain barrier poorly and acts mainly outside the brain; in the United States it has also been studied for gastroparesis.
Go to the active ingredient →Active ingredientMetopimazineCat. No. P-M109-001CAS 14008-44-7
Isotopically labelledMetopimazine-d6Cat. No. P-M109-003CAS 1215315-86-8
Isotopically labelledMetopimazine-d6 SulfoxideCat. No. P-M109-004
Impurity2-Methylsulfonyl-10H-phenothiazineCat. No. P-M109-005CAS 23503-68-6
ImpurityMetopimazine Acid HClCat. No. P-M109-006
ImpurityMetopimazine SulfoxideCat. No. P-M109-007CAS 18181-99-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.